| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | -4.4% |
| Cost of Revenue | $204K | +9.7% |
| R&D Expense | $42.8M | +26.6% |
| SG&A Expense | $23.9M | +18.1% |
| Operating Income | -$64.3M | -24.8% |
| Interest Expense | $297K | -78.8% |
| Net Income | -$61.0M | -24.2% |
| EPS (Basic) | -$1.66 | -12.2% |
| EPS (Diluted) | -$1.66 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.3M | -27.2% |
| Short-term Investments | $44.6M | -21.8% |
| Accounts Receivable | $92K | -7.1% |
| Inventory | $173K | +18.5% |
| Current Assets | $69.2M | -22.4% |
| Total Assets | $76.2M | -20.0% |
| Current Liabilities | $16.2M | +44.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.6M | -9.6% |
| Capital Expenditures | $289K | +270.5% |
| Investing Cash Flow | $13.1M | +22.5% |
| Financing Cash Flow | $29.2M | -36.9% |
| Free Cash Flow | -$50.8M | -10.0% |
| -12.2% |
| Long-term Debt |
| $15.0M |
| — |
| Total Liabilities | $43.2M | +59.1% |
| Stockholders' Equity | $33.0M | -51.6% |